Skip to content
★ Sign in to follow
CP

Cary Pharmaceuticals Inc.

Related company / holding
漢達
Total declarations
2
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 05 Mar 2021 for 漢達, €443k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Cary Pharmaceuticals Inc.: trading record in brief

This profile gathers the share dealings of Cary Pharmaceuticals Inc. in 漢達. The record holds 2 filings, for trades running from 21 December 2016 to 5 March 2021.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 5 March 2021, reports a transaction in 漢達. Source: insider filings from TWSE / TPEx (MOPS). Past trades are no guide to future returns.

Companies and markets linked to Cary Pharmaceuticals Inc.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ●
    Related company / holdingExecutives漢達
    €443kest.0MOPS
    575,693 sharesShareTPExTWMOPS:6620:110/03/05:carypharmaceuticalsinc:0qcs1mi
  • ●
    Related company / holdingExecutives漢達
    €1.0Mest.0MOPS
    332,000 sharesShareTPExTWMOPS:6620:105/12/21:carypharmaceuticalsinc:1sf69ef

2 of 2 declarations